1. Home
  2. AXTI vs BBOT Comparison

AXTI vs BBOT Comparison

Compare AXTI & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXT Inc

AXTI

AXT Inc

HOLD

Current Price

$32.54

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo BridgeBio Oncology Therapeutics Inc.

BBOT

BridgeBio Oncology Therapeutics Inc.

N/A

Current Price

$10.46

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AXTI
BBOT
Founded
1986
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
AXTI
BBOT
Price
$32.54
$10.46
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$24.50
$24.00
AVG Volume (30 Days)
6.9M
283.4K
Earning Date
05-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
35.71
N/A
EPS
N/A
N/A
Revenue
$99,361,000.00
N/A
Revenue This Year
$44.70
N/A
Revenue Next Year
$42.23
N/A
P/E Ratio
N/A
N/A
Revenue Growth
31.09
N/A
52 Week Low
$1.13
$8.70
52 Week High
$47.00
$14.87

Technical Indicators

Market Signals
Indicator
AXTI
BBOT
Relative Strength Index (RSI) 53.36 46.57
Support Level $2.56 $10.03
Resistance Level N/A $12.51
Average True Range (ATR) 4.95 0.64
MACD 0.23 0.03
Stochastic Oscillator 42.77 46.15

Price Performance

Historical Comparison
AXTI
BBOT

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About BBOT BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Share on Social Networks: